Insider · CIK 0001556270
Jonathan Jay Mazelsky
directorceopresidentofficer
Files at XRAY (DENTSPLY SIRONA Inc.), IDXX (IDEXX LABORATORIES INC /DE), PODD (INSULET CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | PODD INSULET CORP | AGrant or award Common Stock | +141 | $130.47 | $18k | 1,496 | 10 d ago |
| Sep 30, 2026 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Phantom Stock (Directors' Deferred Compensation) DDCderivative | +3,323 | $9.03 | $30k | 23,345 | 10 d ago |
| Jul 11, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +279 | $0.00 | $0 | 28,092 | Jul 15, 2025 |
| Jul 11, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Phantom Stock (Directors' Deferred Compensation) DDCderivative | +75 | $16.20 | $1,215 | 9,234 | Jul 15, 2025 |
| Jul 1, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Phantom Stock (Directors' Deferred Compensation) DDCderivative | +1,561 | $16.01 | $25k | 9,159 | Jul 2, 2025 |
| May 22, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +13,880 | $0.00 | $0 | 27,812 | May 27, 2025 |
| Apr 11, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +148 | $0.00 | $0 | 13,932 | Apr 15, 2025 |
| Apr 11, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Phantom Stock (Directors' Deferred Compensation) DDCderivative | +75 | $12.47 | $934 | 7,598 | Apr 15, 2025 |
| Mar 31, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Phantom Stock (Directors' Deferred Compensation) DDCderivative | +1,687 | $14.82 | $25k | 7,523 | Apr 2, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +689 | $0.00 | $0 | 82,447 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +958 | $0.00 | $0 | 83,405 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +1,100 | $0.00 | $0 | 84,505 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | FTax withholding Common Stock | -1,222 | $444.53 | $543k | 83,283 | Feb 18, 2025 |
| Feb 13, 2025 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +25,932 | $0.00 | $0 | 25,932 | Feb 18, 2025 |
| Feb 13, 2025 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -689 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -958 | $0.00 | $0 | 958 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -1,100 | $0.00 | $0 | 2,198 | Feb 18, 2025 |
| Jan 10, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +115 | $0.00 | $0 | 13,785 | Jan 14, 2025 |
| Jan 10, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Phantom Stock (Directors' Deferred Compensation) DDCderivative | +39 | $18.51 | $713 | 5,836 | Jan 14, 2025 |
| Dec 30, 2024 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Phantom Stock (Directors' Deferred Compensation) DDCderivative | +1,340 | $18.65 | $25k | 5,797 | Jan 2, 2025 |
| Oct 11, 2024 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +80 | $0.00 | $0 | 13,669 | Oct 15, 2024 |
| Oct 11, 2024 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Phantom Stock (Directors' Deferred Compensation) DDCderivative | +23 | $24.50 | $560 | 4,457 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.